Bodyport Is A Digital Therapeutics Company Based In San Franciscofounded In 2015 By Corey Centen And Sarah Smiththe Company Specializes In Noninvasive Cardiovascular Monitoring Solutionsfocusing On Managing Chronic Conditions Like Heart Failurebodyport Has Developed Proprietary Hardware And Software Platforms To Support This Mission One Of Its Key Products Is The Bodyport Cardiac Scalea Sensor Equipped Scale That Measures Important Hemodynamic Biomarkers Through Foot Based Signalsthis Device Allows For Real Time Data Transmission To Care Teamsfacilitating Remote Monitoring Of Cardiovascular Healthadditionallybodyport Offers A Clinical Dashboard That Provides Healthcare Providers With Actionable Insights To Identify At Risk Patients And Optimize Therapythe Platform Aims To Enhance The Patient Experience By Enabling Individuals To Track Their Health Metrics And Receive Personalized Guidance With A Commitment To Improving Chronic Disease Managementbodyport Is Positioned At The Intersection Of Digital Health And Medical Device Innovationtargeting Both Patients With Heart Failure And Healthcare Providers
